MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BLTE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Belite Bio (BLTE) Ownership - Who owns Belite Bio?

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1)... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
41
Web
https://www.belitebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.81B
P/E Ratio
N/A
Total Cash
275.61M
Projected Growth
N/A
Total Debt
510K
Revenue
N/A
Risk (Beta)
-0.28
Dividend Yield
N/A
Total Cash/Share
6.88
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BLTE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for BLTE
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
41
Web
https://www.belitebio.com